Health Publications Limited 05765327 false 2023-04-06 2024-04-05 2024-04-05 The principal activity of the company is other business support services Digita Accounts Production Advanced 6.30.9574.0 true 05765327 2023-04-06 2024-04-05 05765327 2024-04-05 05765327 core:RetainedEarningsAccumulatedLosses 2024-04-05 05765327 core:ShareCapital 2024-04-05 05765327 core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss core:Non-currentFinancialInstruments 2024-04-05 05765327 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-05 05765327 core:FurnitureFittingsToolsEquipment 2024-04-05 05765327 bus:SmallEntities 2023-04-06 2024-04-05 05765327 bus:AuditExemptWithAccountantsReport 2023-04-06 2024-04-05 05765327 bus:FilletedAccounts 2023-04-06 2024-04-05 05765327 bus:SmallCompaniesRegimeForAccounts 2023-04-06 2024-04-05 05765327 bus:RegisteredOffice 2023-04-06 2024-04-05 05765327 bus:Director1 2023-04-06 2024-04-05 05765327 bus:PrivateLimitedCompanyLtd 2023-04-06 2024-04-05 05765327 core:FurnitureFittings 2023-04-06 2024-04-05 05765327 core:FurnitureFittingsToolsEquipment 2023-04-06 2024-04-05 05765327 countries:EnglandWales 2023-04-06 2024-04-05 05765327 2023-04-05 05765327 core:FurnitureFittingsToolsEquipment 2023-04-05 05765327 2022-04-06 2023-04-05 05765327 2023-04-05 05765327 core:RetainedEarningsAccumulatedLosses 2023-04-05 05765327 core:ShareCapital 2023-04-05 05765327 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-05 05765327 core:FurnitureFittingsToolsEquipment 2023-04-05 iso4217:GBP xbrli:pure

Registration number: 05765327

Health Publications Limited

Unaudited Filleted Financial Statements

for the Year Ended 5 April 2024

 

Health Publications Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Health Publications Limited

Company Information

Director

Mr W McGregor

Registered office

3 Summerfields Avenue
Halesowen
Birmingham
B62 9NP

Accountants

Ballards LLP
Chartered Accountants
Oakmoore Court
11c Kingswood Road
Hampton Lovett
Droitwich
Worcestershire
WR9 0QH

 

Health Publications Limited

(Registration number: 05765327)
Balance Sheet as at 5 April 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

-

378

Investments

5

8,650

8,650

Other financial assets

6

514,728

546,331

 

523,378

555,359

Current assets

 

Cash at bank and in hand

 

18,487

7,514

Creditors: Amounts falling due within one year

7

(109,829)

(97,298)

Net current liabilities

 

(91,342)

(89,784)

Net assets

 

432,036

465,575

Capital and reserves

 

Called up share capital

1

1

Retained earnings

432,035

465,574

Shareholders' funds

 

432,036

465,575

For the financial year ending 5 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 2 August 2024
 

.........................................
Mr W McGregor
Director

   
     
 

Health Publications Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
3 Summerfields Avenue
Halesowen
Birmingham
B62 9NP

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Health Publications Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and Fittings

25% Straight Line

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Health Publications Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

 

Health Publications Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 6 April 2023

3,780

3,780

At 5 April 2024

3,780

3,780

Depreciation

At 6 April 2023

3,402

3,402

Charge for the year

378

378

At 5 April 2024

3,780

3,780

Carrying amount

At 5 April 2024

-

-

At 5 April 2023

378

378

5

Investments

2024
£

2023
£

Other investments

8,650

8,650

 

Health Publications Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024

6

Other financial assets (current and non-current)

Financial assets at fair value through profit and loss
£

Total
£

Non-current financial assets

Cost or valuation

At 6 April 2023

546,331

546,331

Fair value adjustments

15,402

15,402

Additions

158,944

158,944

Disposals

(205,949)

(205,949)

At 5 April 2024

514,728

514,728

Impairment

Carrying amount

At 5 April 2024

514,728

514,728

7

Creditors

2024
£

2023
£

Due within one year

Amounts owed to related parties

105,442

92,442

Other creditors

4,387

4,856

109,829

97,298